| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 1044-1051, Copyright © 1994 by Endocrine Society
ARTICLES |
H Peegel, J Randolph Jr, AR Midgley and KM Menon
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor 48109-0278.
Previous studies have shown that injection of a pharmacological dose of hCG to rats primed with PMSG/hCG results in a loss of hCG binding in the luteinized ovary, which is closely coupled with the loss of LH/hCG receptor (LH/hCG-R) messenger RNA (mRNA). The time course of down- regulation of the receptor mRNA reveals that mRNA totally disappears 24 h after the hormone injection, but fully recovers by 72 h. The purpose of this study was to determine by in situ hybridization whether the recovery of the receptor mRNA occurs in preexisting or newly formed corpora lutea. Twenty-one-day-old female rats were treated with 50 IU PMSG, followed 56 h later by a single injection of hCG. On day 5 after the hCG injection, one group of rats was treated with a desensitizing dose of hCG, and a control group received saline. The ovaries were collected 6, 12, 24, 48, 72, and 96 h after the treatments and were processed for in situ hybridization using 35S antisense RNA synthesized from a 750-mer LH/hCG-R complementary DNA. In control ovaries, heavily labeled LH/hCG-R mRNA-containing cells were observed in the numerous corpora lutea. Ribonuclease pretreatment of the sections eliminated the signal, and no specific hybridization was observed when sense strand probe was used. No hybridization to the granulosa cells was seen. Some hybridization occurred to the theca interna, but the intensity was lower than that in the corpora lutea. Time-course studies showed a marked decline in the hCG-R mRNA signals in corpora lutea as early as 6 h after hCG injection, with a maximum loss of receptor mRNA by 24 h. After 48 h, hCG-R mRNA reappeared in preexisting corpora lutea, with the intensity of the hybridization signal equaling that in corpora lutea of controls. New corpora lutea could not be identified at any time after injection of the down-regulating dose of hCG. As down- regulated receptor mRNA recovered in preexisting, not new, corpora lutea, hormone-induced loss of luteal cell receptors would appear to be reversible.
This article has been cited by other articles:
![]() |
C. Stocco, C. Telleria, and G. Gibori The Molecular Control of Corpus Luteum Formation, Function, and Regression Endocr. Rev., February 1, 2007; 28(1): 117 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nair, H. Peegel, and K. M. J. Menon The Role of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor-Specific mRNA Binding Protein in Regulating Receptor Expression in Human Ovarian Granulosa Cells J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2239 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nair and K. M. J. Menon Regulation of Luteinizing Hormone Receptor Expression: EVIDENCE OF TRANSLATIONAL SUPPRESSION IN VITRO BY A HORMONALLY REGULATED mRNA-BINDING PROTEIN AND ITS ENDOGENOUS ASSOCIATION WITH LUTEINIZING HORMONE RECEPTOR mRNA IN THE OVARY J. Biol. Chem., December 30, 2005; 280(52): 42809 - 42816. [Abstract] [Full Text] [PDF] |
||||
![]() |
E C Chin, T E Harris, and D R E Abayasekara Changes in cAMP-dependent protein kinase (PKA) and progesterone secretion in luteinizing human granulosa cells J. Endocrinol., October 1, 2004; 183(1): 39 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nair and K. M. J. Menon Isolation and Characterization of a Novel trans-Factor for Luteinizing Hormone Receptor mRNA from Ovary J. Biol. Chem., April 9, 2004; 279(15): 14937 - 14944. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M.J. Menon, U. M. Munshi, C. L. Clouser, and A. K. Nair Regulation of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Expression: A Perspective Biol Reprod, April 1, 2004; 70(4): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nair, J. C. Kash, H. Peegel, and K. M. J. Menon Post-transcriptional Regulation of Luteinizing Hormone Receptor mRNA in the Ovary by a Novel mRNA-binding Protein J. Biol. Chem., June 7, 2002; 277(24): 21468 - 21473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, H. Peegel, and K. M. J. Menon In Situ Hybridization of High Density Lipoprotein (Scavenger, Type 1) Receptor Messenger Ribonucleic Acid (mRNA) during Folliculogenesis and Luteinization: Evidence for mRNA Expression and Induction by Human Chorionic Gonadotropin Specifically in Cell Types that Use Cholesterol for Steroidogenesis Endocrinology, July 1, 1998; 139(7): 3043 - 3049. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |